Patrick Chuinard is listed as an executive officer and director on 3 SEC Form D filings by 1 issuer between Aug 2023 and May 2024: Gerosynth Laboratories, Inc. (Bloomington, MN — industry reported as "Other" — 2023–2024; $2.68M reported sold to 34 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Alisha O'Dell (3 shared filings), Bethany Pope (3 shared filings), Brian Hatlevig (3 shared filings) and Erin Clark (3 shared filings).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Patrick. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 3 public filings for Patrick Chuinard and found 9 differences, 3 worth asking the sponsor about: 29% of the money raised went to insiders; 27% of the money raised went to insiders; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.